CClinicalTrials.gg
Status unknownNCT01618149Updated Jun 13, 2012

Use Quantitative Microradiography to Predict the Periprosthetic Bone Loss in Distal Femur After Total Knee Arthroplasty

An observational study in Periprosthetic Bone Loss in Total Knee Replacement, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to female participants aged 50 Years to 70 Years. Per ClinicalTrials.gov, last updated 2012-06-13.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified Jun 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
50 Years to 70 Years
Sex
Female
01

Study summary

The investigators hypothesized that the microarchitecture of bone influence the degree of periprosthetic bone loss after total knee arthroplasty surgery. The investigators collected the bone fragment at the distal femur while performing total knee replacement and take quantitative radiography analysis . Before and after the surgery(6 month ,12 month) , the investigators check the BMD at identical location of the distal femur by using dual energy absorptiometry. The investigators will use linear regression to evaluate the relationship between the microarchitecture and the degree of bone loss.

02

Conditions studied

  • Periprosthetic Bone Loss in Total Knee Replacement

Keywords

  • osteoarthritis
  • periprosthetic bone loss
  • dual energy x-ray absorptiometry
03

In context

Bone Diseases, Metabolic

470 studies on the registry are indexed under Bone Diseases, Metabolic; 71 are open to participants now.

This study's planned enrollment of 50 is below the median of 81 across 103 observational studies indexed under Bone Diseases, Metabolic.

Browse Bone Diseases, Metabolic studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

the patients who are indicated for total knee arthroplasty and are post menopausal women. The patients who had history of immune disease , fracture of the femur and end stage of renal disease will be excluded

Inclusion criteria

  • severe knee osteoarthritis
  • post menopausal women

Exclusion criteria

Exclusion Criteria:

  • immune disease
  • end stage of renal disease who receive dialysis
  • history of fracture at ipsilateral distal femur
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Biospecimen retention
Samples with dna

Groups and cohorts

  • severe knee OA who are indicated for total knee arthroplasty

    the woman who are indicated for TKR and are post menopausal will be recruited in this study. We will excluded the patients who had immune disease ,previous fracture of femur and end stage of renal disease

    Radiation: dual energy x-ray absorptiometry

Interventions

  • Radiationdual energy x-ray absorptiometry

    before the surgery of total knee arthroplasty and after the surgery 6 months and 12 months

06

What researchers measure

Primary outcomes

  1. change in bone mineral density

    Use dual energy x-ray absorptiometry to detect to BMD at the distal femur

    Time frame: before the surgery and after the sugery (6month ,12month)

07

Study locations

1 site
  • National taiwan university hospital
    Taipei, 100, Taiwan
    • Ching Chuan Jiang, professoir · Contact · ccj@ntu.edu.tw · 886223123456
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 13, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01618149
Lead sponsor
National Taiwan University Hospital
Responsible party
National Taiwan University Hospital (Use dual-energy x-ray absorptiometry and quantative microradiography to predict the periprosthetic bone loss in distal femur after total knee arthroplasty, National Taiwan University Hospital) — Sponsor-investigator
First posted
Jun 13, 2012
Start date
Jul 2012
Primary completion
Jul 2013 (estimated)
Completion
Jul 2013 (estimated)
Last update
Jun 13, 2012

Study contacts

Ching Chuan Jiang, professor
Contact
ccj@ntu.edu.tw
23123456 ext. 65273
Wei cheng Huang, resident
Contact
osteocheng@gmail.com
ching chuan Jiang, professor
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion